Amicus Therapeutics (FOLD) Misses Q4 EPS by 6c

Amicus Therapeutics (NASDAQ: FOLD) reported Q4 EPS of ($0.24), $0.06 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Orosur Mining launches private placement targeting C$14M
• Worthington Industries (WOR) Tops Q1 EPS by 7c